BioSpace News Archive

Business

PhinC Development opens subsidiary PhInc. Modeling in Montreal, Canada

The French company PhinC Development, specialized in simulation and modeling strategy for drug development, strengthens its presence in North America to significantly develop its business and increase its turnover.

October 22, 2019
·
3 min read
“Automation for all” PAA shows the way at ELRIG Drug Discovery 2019

Low-cost, flexible and dependable automation possibilities open up for any research group

October 22, 2019
·
2 min read
Business

Metastatic Breast Cancer Alliance Brings Awareness to Clinical Trials in Advance of the Release of MBC Connect 2.0

National Nonprofit’s Enhanced Mobile App and Online Platform will Potentially Match Patients with Clinical Trials

October 22, 2019
·
7 min read
Biotech Bay

New Synthego Program Provides Unprecedented Editing of iPS

Genome engineering company Synthego launched a new genome editing program to include induced pluripotent stem cells, adult cells that can be reprogrammed and provide researchers with an easier pathway to drug development.

October 22, 2019
·
2 min read
·
Alex Keown
Policy

Centrient Pharmaceuticals Initiates a Second Patent Litigation in India Against Dalas Biotech Limited

Centrient Pharmaceuticals (“Centrient”), the global leader in the production and commercialisation of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has

October 22, 2019
·
2 min read
Drug Development

PBL gains approval to advance next generation anthrax vaccine to Phase 1 clinical trial

Porton Biopharma Ltd has announced that it has signed a modification to its contract with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases to advance a next generation intra-nasal anthrax vaccine into the clinical-trial phase.

October 22, 2019
·
1 min read
Drug Development

Halted phase III clinical trial for Alzheimer’s shows renewed promise

The pharmaceutical company Biogen announced they plan to file for US marketing approval of the potential Alzheimer’s drug, aducanumab.

October 22, 2019
·
1 min read
Researchers begin trial of drug to slow progression of neurodegenerative condition Multiple System Atrophy

Researchers at UCL Queen Square Institute of Neurology and the UCLH National Hospital for Neurology & Neurosurgery are set to test whether a drug can slow progression of the devastating neurodegenerative condition Multiple System Atrophy

October 22, 2019
·
5 min read
FDA

Vertex Wins Approval for Triple Combination Drug Expected to Treat 90% of CF Patients

The U.S. Food and Drug Administration approved a new cystic fibrosis medication that is expected to provide treatment for 90% of patients with this debilitating and life-shortening condition.

October 22, 2019
·
3 min read
·
Alex Keown
Business

Neumentum’s CEO Discusses Deal With J&J for Non-Opioid Acute Pain Treatment

Chief Executive Officer Scott Shively said the acquisition of an oral analgesic from Johnson & Johnson will be transformative for California-based Neumentum Inc.

October 22, 2019
·
3 min read
·
Alex Keown